[Entacapone in the therapy of Parkinson disease].
Teräväinen
H
H
HYKS:n neurologian klinikka Haartmaninkatu 4, 00290 Helsinki. heikki.teravainen@kolumbus.fi
D000978:Antiparkinson Agents / Q000494:pharmacology / Q000627:therapeutic use*; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009570:Nitriles; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D065098:Catechol O-Methyltransferase Inhibitors; D002396:Catechols; D004791:Enzyme Inhibitors; D009570:Nitriles; C071192:entacapone